Mid-Afternoon Market Update: Dow Jumps Over 300 Points; Fed Boosts Interest Rates by 0.75%
U.S. stocks traded higher toward the end of trading, after the Federal Reserve raised interest rates by 0.75%.
Mid-Day Market Update: Nasdaq Rises 200 Points; 180 Life Sciences Shares Plummet
U.S. stocks traded higher midway through trading, with the Nasdaq Composite gaining more than 200 points on Wednesday.
55 Stocks Moving In Wednesday’s Mid-Day Session
Gainers
Sidus Space, Inc. (NASDAQ: SIDU) shares surged 92.4% to $2.77 after the company announced it is part of Collins Aerospace team which was awarded NASA's Exploration Extravehicular Activity services contract with a potential value of $3.5 billion.
Why Kintara Therapeutics Shares Are Skyrocketing Today
Kintara Therapeutics Inc (NASDAQ: KTRA) shares are trading higher by 28.6% to $0.24 after the FDA granted Fast Track Designation to the company’s VAL-083.
Kintara Therapeutics’ Stock Shooting Higher As FDA Grants Fast Track Designation To Brain Cancer Drug
The United States Food and Drug Administration (FDA) has granted Fast Track Designation to Kintara Therapeutics’ (NASDAQ: KTRA) lead drug candidate VAL-083 for the treatment of patients with newly-diagnosed unmethylated glioblastoma (GBM).
70 Stocks Moving In Monday’s Mid-Day Session
Gainers
Day One Biopharmaceuticals, Inc. (NASDAQ: DAWN) shares jumped 110% to $13.93 after the company announced initial data from the pivotal FIREFLY-1 trial of tovorafenib in relapsed pediatric low-grade glioma showed an overall response rate of 64%.
30 Stocks Moving in Monday’s Pre-Market Session
Gainers
G Medical Innovations Holdings Ltd (NASDAQ: GMVD) rose 53.6% to $0.5301 in pre-market trading after dropping more than 28% on Friday.
69 Biggest Movers From Yesterday
Gainers
Powerbridge Technologies Co., Ltd. (NASDAQ: PBTS) shares climbed 189.9% to close at $1.12 on Thursday.
Dawson James Downgrades Kintara Therapeutics to Neutral
Dawson James analyst Jason Kolbert downgrades Kintara Therapeutics (NASDAQ:KTRA) from Buy to Neutral.